The exploratory investigation of ganciclocir vitreous injection fro Cytomegalo virus (CMV) retinitis

The exploratory investigation of ganciclocir vitreous injection fro Cytomegalo virus (CMV) retinitis - Treatment for CMV retinitis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017339

Enrollment

Registered

2015-05-01

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cytomegalovirus retinitis

Interventions

ganciclovir vitreous injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who have cytomegalovirus retinitis

Exclusion criteria

Exclusion criteria: sevire corneal epithelium disorder

Design outcomes

Primary

Measure	Time frame
improvement of retinitis	—

Countries

Japan

Contacts

Public ContactKazuichi Maruyama

Tohoku University Graduate School of Medicine Ophthalmology

maruyama-k@oph.med.tohoku.ac.jp022-717-7294

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026